Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC

PLoS ONE

Volumn 5, Issue 7, 2010, Pages 1-14

  Tang, Jing Yan ^a   Li, Shang ^a   Li, Zhen Hua ^a   Zhang, Zai Jun ^a   Hu, Guang ^a   Cheang, Lorita Chi Veng ^a   Alex, Deepa ^a   Hoi, Maggie Pui Man ^a   Kwan, Yiu Wa ^b   Chan, Shun Wan ^c   Leung, George Pak Heng ^d   Lee, Simon Ming Yuen ^a  

^a University of Macau   (Macao)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CALYCOSIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOFLAVONOID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RALOXIFENE; TAMOXIFEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; 7,3' DIHYDROXY 4' METHOXYISOFLAVONE; 7,3'-DIHYDROXY-4'-METHOXYISOFLAVONE; ISOFLAVONE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING; ZEBRA FISH; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BINDING; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; ENDOTHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; ISOFLAVONES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; UMBILICAL VEINS; ZEBRAFISH;

EID: 77955591123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011822     Document Type: Article

References (63)

1. Franco CA, Liebner S, Gerhardt H (2009) Vascular morphogenesis: a Want for every vessel? Curr Opin Genet Dev 19: 476-483.
2. Barkhem T, Nilsson S, Gustafsson JA (2004) Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am J Pharmacogenomics 4: 19-28.
3. Losordo DW, Isner JM (2001) Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 21: 6-12.
4. Kim KH, Moriarty K, Bender JR (2008) Vascular cell signaling by membrane estrogen receptors. Steroids 73: 864-869.
5. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, et al. (1996) Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94: 1402-1407.
6. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, et al. (1995) Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763.
7. Doshida M, Ohmichi M, Tsutsumi S, Kawagoe J, Takahashi T, et al. (2006) Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells. J Biol Chem 281: 24270-24278.
8. Valachovicova T, Slivova V, Sliva D (2004) Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem 4: 881-887.
9. Kostelac D, Rechkemmer G, Briviba K (2003) Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 51: 7632-7635.
10. Seng WL, Eng K, Lee J, McGrath P (2004) Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Angiogenesis 7: 243-253.
11. Chen XJ, Bian ZP, Lu S, Xu JD, Gu CR, et al. (2006) Cardiac protective effect of Astragalus on viral myocarditis mice: comparison with Perindopril. Am J Chin Med 34: 493-502.
12. Zhao Z, Wang W, Wang F, Zhao K, Han Y, et al. (2009) Effects of Astragaloside IV on heart failure in rats. Chin Med 4: 6.
13. Xu XL, Ji H, Gu SY, Shao Q, Huang QJ, et al. (2008) Cardioprotective effects of Astragali Radix against isoproterenol-induced myocardial injury in rats and its possible mechanism. Phytother Res 22: 389-394.
14. He J, Jing Z, Gu Q (1999) Collagen expression of intra-acinar pulmonary arteries and right ventricle and intervention of Radix Astragali in rats with hypoxic pulmonary hypertension. Zhonghua Yi Xue Za Zhi 79: 654-656.
15. Xi S, Ruan Y, Liu Y (1998) Morphometric investigation on hypoxic structural remodeling of intraacinar pulmonary arteries. Zhonghua Jie He He Hu Xi Za Zhi 21: 303-305.
16. Chen X, Ruan Y, Xi S, Si W, Zhang L (1997) Therapeutic effect of radix Astragali on hypoxia pulmonary hypertension in rats. Zhongguo Zhong Yao Za Zhi 22: 432-434, inside back cover.
17. Liu JC, An CS, Wang JF, Li FY, Li JH (2006) Influence of Radix Astragali on nitric oxide and endothelin-1 in pulmonary tissue in hypoxemic pulmonary hypertension in rats. Zhonghua Er Ke Za Zhi 44: 46-48.
18. Liu K (1990) Preliminary report on various symptoms of chronic hepatitis treated with radix Astragali and its regulative effect on levels of serum hormone. Zhong Xi Yi Jie He Za Zhi 10: 330-333, 323.
19. Chan CM, Chan YW, Lau CH, Lau TW, Lau KM, et al. (2007) Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis. J Ethnopharmacol 109: 10-20.
20. Xu A, Wang H, Hoo RL, Sweeney G, Vanhoutte PM, et al. (2009) Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 150: 625-633.
21. Cai XY, Xu YL, Lin XJ (2006) Effects of radix Astragali injection on apoptosis of lymphocytes and immune function in patients with systemic lupus erythematosus. Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 443-445.
22. Choi RC, Gao QT, Cheung AW, Zhu JT, Lau FT, et al. (2009) A Chinese Herbal Decoction, Danggui Buxue Tang, Stimulates Proliferation, Differentiation and Gene Expression of Cultured Osteosarcoma Cells: Genomic Approach to Reveal Specific Gene Activation. Evid Based Complement Alternat Med.
23. Song ZH, Ji ZN, Lo CK, Dong TT, Zhao KJ, et al. (2004) Chemical and biological assessment of a traditional chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis: orthogonal array design to optimize the extraction of chemical constituents. Planta Med 70: 1222-1227.
24. Dong TT, Zhao KJ, Gao QT, Ji ZN, Zhu TT, et al. (2006) Chemical and biological assessment of a chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: Determination of drug ratio in having optimized properties. J Agric Food Chem 54: 2767-2774.
25. Gao QT, Choi RC, Cheung AW, Zhu JT, Li J, et al. (2007) Danggui buxue tang-a Chinese herbal decoction activates the phosphorylations of extracellular signal-regulated kinase and estrogen receptor alpha in cultured MCF-7 cells. FEBS Lett 581: 233-240.
26. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN (2006) Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27: 297-309.
27. Shi ZY, Bao Z, Jiang Y, Tu PF (2007) Quantitative analysis of calycosin glycoside and formononetin in Radix astragali from different sources. Zhongguo Zhong Yao Za Zhi 32: 779-783.
28. Song JZ, Yiu HH, Qiao CF, Han QB, Xu HX (2008) Chemical comparison and classification of Radix Astragali by determination of isoflavonoids and astragalosides. J Pharm Biomed Anal 47: 399-406.
29. Fan Y, Wu DZ, Gong YQ, Zhou JY, Hu ZB (2003) Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells. Eur J Pharmacol 481: 33-40.
30. Zhang Y, Hu G, Lin HC, Hong SJ, Deng YH, et al. (2009) Radix Astragali extract promotes angiogenesis involving vascular endothelial growth factor receptor-related phosphatidylinositol 3-kinase/Akt-dependent pathway in human endothelial cells. Phytother Res 23: 1205-1213.
31. Siekmann AF, Lawson ND (2007) Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445: 781-784.
32. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, et al. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
33. Klagsbrun M, D'Amore PA (1996) Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7: 259-270.
34. Zachary I (2001) Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 280: C1375-1386.
35. Furet P, Bold G, Hofmann F, Manley P, Meyer T, et al. (2003) Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorg Med Chem Lett 13: 2967-2971.
36. Bracamonte MP, Rud KS, Miller VM (2002) Mechanism of raloxifene-induced relaxation in femoral veins depends on ovarian hormonal status. J Cardiovasc Pharmacol 39: 704-713.
37. Jordan VC (2006) Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br J Pharmacol 147 Suppl 1: S269-276.
38. Cid MC, Schnaper HW, Kleinman HK (2002) Estrogens and the vascular endothelium. Ann N Y Acad Sci 966: 143-157.
39. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, et al. (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitricoxide synthase activation by estrogen. J Biol Chem 278: 2118-2123.
40. Johns A, Freay AD, Fraser W, Korach KS, Rubanyi GM (1996) Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology 137: 4511-4513.
41. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
42. Pages G, Milanini J, Richard DE, Berra E, Gothie E, et al. (2000) Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann N Y Acad Sci 902: 187-200.
43. Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362.
44. Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543.
45. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
46. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
47. Fong TA, Shawver LK, Sun L, Tang C, App H, et al. (1999) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59: 99-106.
48. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
49. Park JE, Chen HH, Winer J, Houck KA, Ferrara N (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654.
50. Wren BG (2009) The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women. Med J Aust 190: 321-325.
51. Conner P, Lundstrom E, von Schoultz B (2008) Breast cancer and hormonal therapy. Clin Obstet Gynecol 51: 592-606.
52. Leung FP, Yung LM, Leung HS, Au CL, Yao X, et al. (2007) Therapeuti concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro. Br J Pharmacol 152: 223-229.
53. Leung HS, Yung LM, Leung FP, Yao X, Chen ZY, et al. (2006) Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms. Br J Pharmacol 149: 703-711.
54. Pinna C, Bolego C, Sanvito P, Pelosi V, Baetta R, et al. (2006) Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta. J Pharmacol Exp Ther 319: 1444-1451.
55. Wong CM, Yung LM, Leung FP, Tsang SY, Au CL, et al. (2008) Raloxifene protects endothelial cell function against oxidative stress. Br J Pharmacol 155: 326-334.
56. Murphey RD, Stern HM, Straub CT, Zon LI (2006) A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 68: 213-219.
57. Kuida K, Boucher DM (2004) Functions of MAP kinases: insights from genetargeting studies. J Biochem 135: 653-656.
58. Uchiba M, Okajima K, Oike Y, Ito Y, Fukudome K, et al. (2004) Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo. Circ Res 95: 34-41.
59. Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, et al. (1999) 17 Betaestradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 40: 2122-2129.
60. Geraldes P, Sirois MG, Tanguay JF (2003) Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93: 399-405.
61. Westerfield M (1995) The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 3rd Edition Eugene, OR, University of Oregon Press. 385 p.
62. Wilkinson JM, Hayes S, Thompson D, Whitney P, Bi K (2008) Compound profiling using a panel of steroid hormone receptor cell-based assays. J Biomol Screen 13: 755-765.
63. Merchan JR, Chan B, Kale S, Schnipper LE, Sukhatme VP (2003) In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. J Natl Cancer Inst 95: 388-399.